These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Long-term outcome of treatment with ruxolitinib in myelofibrosis. Tefferi A; Litzow MR; Pardanani A N Engl J Med; 2011 Oct; 365(15):1455-7. PubMed ID: 21995409 [No Abstract] [Full Text] [Related]
12. [Ruxolitinib prescription in myelofibrosis]. Lemal R; Robin M; Ravinet A; Cacheux V; Guièze R; Bay JO Bull Cancer; 2013 Sep; 100(9):897-902. PubMed ID: 23985569 [TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib for myelofibrosis therapy: current context, pros and cons. Pardanani A Leukemia; 2012 Jul; 26(7):1449-51. PubMed ID: 22285996 [No Abstract] [Full Text] [Related]
14. Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis. Caocci G; Maccioni A; Murgia F; Perra A; Usai M; Piga M; Mascia R; La Nasa G Leuk Lymphoma; 2016 May; 57(5):1215-8. PubMed ID: 26308187 [No Abstract] [Full Text] [Related]
15. Klebsiella pneumoniae primary liver abscess associated with ruxolitinib. Kusano Y; Terui Y; Ueda K; Hatake K Ann Hematol; 2016 Sep; 95(9):1561-2. PubMed ID: 27259987 [No Abstract] [Full Text] [Related]
16. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. Stübig T; Alchalby H; Ditschkowski M; Wolf D; Wulf G; Zabelina T; Wolschke C; Ayuk F; Kröger N Leukemia; 2014 Aug; 28(8):1736-8. PubMed ID: 24569777 [No Abstract] [Full Text] [Related]
17. Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients. Bjørn ME; Holmström MO; Hasselbalch HC Leuk Lymphoma; 2016; 57(1):125-8. PubMed ID: 25936872 [TBL] [Abstract][Full Text] [Related]
18. Improvement of bone marrow fibrosis with ruxolitinib: will this finding change our perception of the drug? Breccia M; Molica M; Colafigli G; Alimena G Expert Rev Hematol; 2015 Aug; 8(4):387-9. PubMed ID: 25915176 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis. Arana Yi C; Tam CS; Verstovsek S Future Oncol; 2015; 11(5):719-33. PubMed ID: 25757677 [TBL] [Abstract][Full Text] [Related]